Washington Trust Advisors Inc. Purchases 3,475 Shares of Veeva Systems Inc. $VEEV

Washington Trust Advisors Inc. grew its holdings in Veeva Systems Inc. (NYSE:VEEV) by 7.5% during the 2nd quarter, HoldingsChannel reports. The firm owned 49,843 shares of the technology company’s stock after acquiring an additional 3,475 shares during the quarter. Washington Trust Advisors Inc.’s holdings in Veeva Systems were worth $8,846,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in the business. Norges Bank bought a new stake in Veeva Systems during the 4th quarter valued at approximately $332,412,000. Durable Capital Partners LP bought a new position in Veeva Systems in the 2nd quarter worth approximately $281,351,000. Fundsmith LLP acquired a new position in shares of Veeva Systems during the second quarter worth approximately $144,955,000. Arrowstreet Capital Limited Partnership boosted its position in shares of Veeva Systems by 203.0% in the first quarter. Arrowstreet Capital Limited Partnership now owns 913,281 shares of the technology company’s stock valued at $160,427,000 after acquiring an additional 611,868 shares during the period. Finally, AQR Capital Management LLC grew its stake in shares of Veeva Systems by 31.2% in the third quarter. AQR Capital Management LLC now owns 2,412,210 shares of the technology company’s stock worth $706,078,000 after acquiring an additional 574,164 shares during the last quarter. Institutional investors and hedge funds own 88.20% of the company’s stock.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Higher outlook and strong operating momentum: Veeva raised its fiscal 2027 outlook as Vault CRM migrations, research-and-development investment and Falcon AI adoption support revenue growth and expanding profitability. This follows a strong latest quarter, in which revenue increased 17.6% year over year to approximately $928 million and adjusted earnings exceeded analyst expectations. VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast
• Positive Sentiment: AI adoption is broadening: Regeneron and Biogen have adopted Veeva’s AI-powered Vault CRM suite globally. Veeva also introduced Falcon Safety, an agentic AI product designed for biopharmaceutical safety operations. These developments could deepen customer relationships and expand Veeva’s role in commercial and safety workflows. Why Is Veeva Systems Winning Big in AI For Biopharma?
• Positive Sentiment: Long-term investor support: Commentary highlights Veeva’s recurring-revenue model, Vault CRM migration opportunity and AI expansion as reasons the stock remains attractive for long-term growth investors. Investor Michael Burry has also reportedly remained bullish on Veeva while criticizing Snowflake’s valuation. Burry Remains Bullish on Veeva
• Neutral Sentiment: Valuation and competition remain important considerations: Analysts and portfolio commentary generally support holding VEEV, but warn that market saturation could limit future growth. With the stock trading at a premium earnings multiple after a substantial rally, investors may require continued execution and strong guidance upgrades. Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
• Negative Sentiment: Insider selling may weigh modestly on sentiment: Veeva’s exiting president sold 10,000 shares for approximately $2.8 million, representing about 51% of the executive’s direct equity stake before the transaction. The sale does not establish a change in business fundamentals, but it can raise caution after the stock’s strong advance. Veeva’s Exiting President Sold $2.8 Million in Stock

Insider Activity

In other Veeva Systems news, insider Thomas Schwenger sold 10,000 shares of the business’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $281.33, for a total value of $2,813,300.00. Following the transaction, the insider directly owned 19,449 shares in the company, valued at $5,471,587.17. The trade was a 33.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

VEEV has been the subject of a number of research reports. Robert W. Baird increased their price target on shares of Veeva Systems from $260.00 to $300.00 and gave the company an “outperform” rating in a report on Thursday, August 27th. Truist Financial lifted their target price on Veeva Systems from $262.00 to $305.00 and gave the stock a “buy” rating in a research report on Thursday, August 27th. Jefferies Financial Group reiterated a “buy” rating and issued a $295.00 price objective on shares of Veeva Systems in a research report on Thursday, August 27th. Morgan Stanley upped their target price on Veeva Systems from $215.00 to $275.00 and gave the company an “equal weight” rating in a research note on Thursday, August 27th. Finally, TD Cowen lifted their price target on shares of Veeva Systems from $235.00 to $283.00 and gave the stock a “buy” rating in a research note on Monday, August 24th. Nineteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $284.46.

Veeva Systems Trading Down 0.4%

VEEV stock opened at $274.02 on Monday. Veeva Systems Inc. has a 1-year low of $148.05 and a 1-year high of $310.50. The firm has a market cap of $44.37 billion, a P/E ratio of 45.07, a P/E/G ratio of 1.17 and a beta of 0.97. The business’s 50 day moving average is $220.49 and its 200-day moving average is $188.04.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings data on Wednesday, August 26th. The technology company reported $2.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $0.12. Veeva Systems had a return on equity of 14.25% and a net margin of 29.34%.The firm had revenue of $927.96 million during the quarter, compared to analyst estimates of $905.38 million. During the same period in the prior year, the company posted $1.99 earnings per share. The business’s revenue for the quarter was up 17.6% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. Sell-side analysts forecast that Veeva Systems Inc. will post 6.7 EPS for the current year.

Veeva Systems Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.